Keyphrases
Radiotherapy
93%
In Cancer
93%
Programmed Death-ligand 1 (PD-L1)
78%
Cancer Cells
77%
Programmed Death-ligand 1 Expression
64%
Radiosensitization
53%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
48%
DNA Damage
48%
Radiosensitivity
47%
PD-L1 Expression
36%
Tumor
34%
X-ray Irradiation
34%
Tumor Microenvironment
34%
DNA Damage Signaling
33%
High Linear Energy Transfer
32%
DNA Double-strand Break Repair
32%
Clonogenic Assay
32%
Indonesian
32%
Glioblastoma multiforme
32%
CD8+ T Cells
28%
Ionizing Radiation
28%
X-ray
27%
Cancer Cell Lines
27%
Overall Survival
24%
Immune Response
24%
Carbon Ion Irradiation
20%
Tumor-infiltrating Immune Cells
20%
Ku80
19%
Genomic Data
19%
Cancer Genomics
19%
PD-L1 Downregulation
18%
3D Structured Illumination Microscopy
18%
Radiation Therapy
18%
5-year Survival
18%
Tumor Immunity
18%
Radiotherapy-induced
18%
Double-strand Break Repair
17%
Repair Pathway
17%
Radioresistance
16%
Forkhead Box P3 (FOXP3)
16%
Cancer Development
16%
Golgi Apparatus
16%
RCAS1
16%
Volumetric Analysis
16%
U2OS Cells
16%
Calreticulin
16%
Megavoltage
16%
Radiation-protective Agents
16%
Ring Finger Protein 8
16%
Red Algae
16%
Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
51%
Nasopharynx Cancer
48%
Radiosensitivity
44%
Cancer Cell
35%
Malignant Neoplasm
34%
Immunocompetent Cell
34%
X-Ray Irradiation
32%
Cancer Cell Line
32%
Tumor Microenvironment
32%
Programmed Death-Ligand 1
32%
Cervical Cancer
32%
Overall Survival
21%
Upregulation
20%
Oncology
20%
Golgi Apparatus
16%
Cell Marker
16%
Prognostic Factor
16%
Quality of Life
16%
Cancer Tissue
16%
Radiosensitizer
16%
Annona muricata
16%
Systematic Review
16%
Epstein-Barr Virus
16%
Clonogenic Assay
16%
Mutational Analysis
16%
Glioblastoma
16%
Calreticulin
16%
COVID-19
16%
Ionizing Radiation
16%
Brain Tumor
16%
Oncoprotein
16%
Non-Homologous End Joining
16%
Elderly Patient
16%
Frailty
16%
Geriatrics
16%
Patient Referral
16%
Acute Toxicity
16%
External Beam Radiotherapy
16%
CD8 Antigen
11%
The Cancer Genome Atlas
9%
Cytotoxic T-Cell
9%
Cancer Therapy
8%
Personalized Medicine
8%
Medical Oncology
8%
Multivariate Analysis
7%
Tumor Progression
7%
Chemoradiotherapy
7%
Tumor Cell
7%
Parietal Lobe
6%
Immunology and Microbiology
Programmed Death 1 Ligand 1
64%
DNA Damage
56%
Radioresistance
49%
X Ray
48%
Cancer Cell
44%
Upregulation
35%
Linear Energy Transfer
32%
FOXP3
32%
Immune Response
30%
Clonogenic Assay
28%
Cytotoxic T-Cell
28%
Cancer Cell Line
24%
Squamous Cell
22%
CD4
21%
Normal Human
20%
Illumination
17%
P53
17%
Caspase
16%
Xenograft
16%
Preclinical Study
16%
Fibroblast
16%
Calreticulin
16%
Red Alga
16%
Cell Cycle Regulation
16%
Excision Repair
16%
Tumor Immunity
16%
Programmed Death-Ligand 1
16%
DNA End Joining Repair
16%
Double Stranded DNA Break
16%
Ring Finger
16%
Human Leukocyte Antigen
16%
Human Cell
16%
Cell Marker
16%
Epstein Barr Virus
16%
CD25
16%
Cancer Tissue
16%
Prostate
16%
Immunocompetent Cell
16%
Regulatory T Cell
16%
Cell Infiltration
13%
CD8
13%
Nonsense Mediated mRNA Decay
12%
Ataxia Telangiectasia
11%
Cell Line
10%
T Cell
8%
Cell Cycle Arrest
8%
Hydrophilicity
8%
Tumor Volume
8%
Medline
8%
Scopus
8%
